Support our fight against COVID-19
We are saving and improving lives every day via our highly effective treatments for all stages of COVID-19. Your gifts help us to expand our reach and share the latest research available, for the health and well-being of all.
Donations directly support FLCCC Alliance research, education, translation, advocacy, lobbying and outreach efforts.
If you have questions about giving, contact us @ 202-985-3227 or [email protected]
Postal contributions: FLCCC Alliance, 2001 L St NW Suite 500, Washington, DC 20036.
Net proceeds from the FLCCC Store directly fund FLCCC Alliance operations.
Did you know? Amazon Smile will donate 0.5% of the price of your eligible Amazon purchases to FLCCC! Simply type: “Front Line Covid 19 Critical Care Alliance Inc” in the Amazon Smile non-profit organization search bar, hit select, and you’re ready to go. Remember, always start at smile.amazon.com to make your purchases, and you’ll be supporting the FLCCC while you shop
Impact Report 2021
The FLCCC Alliance is a 501c3 non-profit organization. Donations are tax deductible to the full extent of the law. Our EIN is 85-2270146.
We are excited to announce that we have opened an online store where you can help to support our lifesaving mission just by purchasing our specially branded merchandise.
Our work to save as many lives as we possible can is urgent—both in the United States and across the world. But it requires that we secure enough revenue for the FLCCC—a 501(c)3 charitable organization—to continue implementation and promotion of our bold, global initiatives. All funds received through purchases will go directly towards fulfillment of our resolve to end this pandemic and save every life we can. Thank you!
The Front Line Covid-19 Critical Care Alliance (FLCCC Alliance) is a 501c3 non-profit organization* founded in March 2020 with the simple goal of developing the most effective treatment protocols possible for COVID-19 patients. Our approach is based on the use of outcome-based medicine by repurposing existing drugs to minimize fatalities and reduce long-term effects in patients suffering from this pandemic.
Our founding members are highly published critical care specialists from major academic medical centers with nearly 2,000 medical publications and numerous major contributions to the field of medicine.
- Check our Mission Statement and Objectives on the About us page
- Watch Dr. Pierre Kory’s Dec 8, 2020 US senate hearing on our Official Testimony page.
- Watch Dr. Pierre Kory’s statements on the effectiveness of ivermectin in the latest data from international studies: Dr. Kory interviewed by Charles Groenhuijsen, Vincent Everts, Dr. Adam Cohen, Professor of Clinical Pharmacology at Leiden University and GP Walter Schrader which used to work in the tropics.
As the pandemic takes its toll on countries and economies worldwide, most governments have focused on vaccine development and vaccine distribution to beat COVID-19.
Thousands of people are suffering and dying while the vaccine is being produced and distributed. It will take months before we reach herd immunity through the vaccine and extended lockdowns may cause immeasurable long-term harm to our economies.
The FLCCC has identified 2 effective therapy protocols that can help slow down the pandemic to alleviate the current burden on our healthcare system and save lives at the same time:
- MATH+ — a combination therapy intended for the hospitalized patient and consisted of the core therapies of methylprednisolone, ascorbic acid, thiamine, and heparin, all delivered intravenously along with multiple adjunctive medicines
- I-MASK+ — a prophylactic and early treatment protocol centered around the use of ivermectin, a historically important medicine that has already won the Nobel Prize in medicine for its global impact in ridding the world of parasitic diseases and that shows promising anti-viral and anti-inflammatory properties against COVID-19
- I-MASS — a protocol created for generalized distribution during mass outbreaks and in low-resource countries. To achieve maximal impact as well as ease of deployment with the lowest burden of required elements, the I-MASS treatment approach is centered on the fewest, core, high impact elements such as the drug Ivermectin.
How else can you support the FLCCC Alliance
- Download and share our MATH+ and I-MASK+ life-saving protocols to your family, friends and doctors.
- Write to your elected officials to review our latest analyses, particularly on the repurposing of ivermectin to fight COVID-19.
- If you, your friend or family has benefited from the MATH+ or I-MASK+ protocols, post a testimonial of your experience on social media or send us an email.
- If your doctor prescribed you ivermectin or any other effective treatments to help fight COVID-19, contact us and connect us to your doctor so we can further study what works and what doesn’t.
*The FLCCC Alliance has been incorporated in the State of Delaware and received 501(c)3 federal tax-exempt status as a public charity [Status: 170(b)(1)(A)(vi); Employer ID number: 85-2270146]. You can download the Determination Letter (IRS) here.
To learn more about our work, please go to About the FLCCC Alliance, there you will also find our Mission Statement and Objectives.